Abstract: A method for evaluation of a thin-layer chromatography plate after performing a separation process that separates components of a sample on the thin-layer chromatography plate comprises a digitization step, wherein at least two digital images are taken that differ with respect to the wavelength range of illumination of the thin-layer chromatography plate. The method further comprises a position identification step wherein the position of the thin-layer chromatography plate is identified for each of the at least two digital images. Furthermore, the method comprises an evaluation step wherein an image information of the at least two digital images is superimposed for at least all regions with at least one visible spot within at least one of the at least two digital images, so that the superimposition of image information from identical regions of at least two digital images can be used for evaluation of the thin-layer chromatography.

Abstract: A device and a method for calibrating a light projector (1) with adaptable luminous elements (3) arranged in an image plane (2), comprising a camera (4) and a control unit (5) connected to the light projector (1) and the camera (4), wherein the light projector (1) is configured to project in temporal succession at least two test images (6, 6?) with at least two comparison structures (9, 9?) from the image plane (2) to an arbitrarily extending projection surface (7), the camera (4) is a depth camera configured to record at least two camera images of a recording surface (8) in a manner substantially synchronized temporally with the light projector (1), and to detect the three-dimensional position data of the comparison structures (9, 9?) in the camera images, and the control unit (5) is configured to determine the position and orientation of the light projector (1), and to calculate the translational displacement and rotational twist between camera (4) and projector (1).

Abstract: The present invention relates to compounds according to general formula (I) which are metabolically robust analogues of bioactive lipid mediators derived from omega-3 polyunsaturated fatty acids (n-3 PUFAs) for use in treating, reducing the risk of developing or preventing a disorder associated with an elevated GDF-15 plasma concentration.

Abstract: The present invention relates to compounds according to general formula (I) which are metabolically robust analogues of bioactive lipid mediators derived from omega-3 polyunsaturated fatty acids (n-3 PUFAs) for use in treating or reducing the risk of developing or preventing: (i) neovascularization and/or (ii) inflammatory disorder, in particular, ophthalmic disorders associated with neovascularization and/or inflammation.

Abstract: The present disclosure relates to a pyrotechnic object, in particular an irritation body, irritation projectile or ammunition, comprising an ignition device, comprising a delay chamber extending along a delay path, in which chamber a delay charge is accommodated, and comprising at least one and preferably a plurality of effect chambers in which or in each of which an effect charge to be ignited is accommodated, wherein the delay chamber is transversely connected to a respective effect chamber via a respective over-ignition opening which branches off from the delay chamber and forms an over-ignition path, wherein in the case of a plurality of effect chambers the plurality of over-ignition openings are arranged successively downstream along the delay path in the order of the effect charges to be ignited.

Abstract: The present disclosure relates to a pyrotechnic object, in particular an irritation body, irritation projectile or ammunition, comprising an ignition device, comprising a delay chamber extending along a delay path, in which chamber a delay charge is accommodated, and comprising at least one and preferably a plurality of effect chambers in which or in each of which an effect charge to be ignited is accommodated, wherein the delay chamber is transversely connected to a respective effect chamber via a respective over-ignition opening which branches off from the delay chamber and forms an over-ignition path, wherein in the case of a plurality of effect chambers the plurality of over-ignition openings are arranged successively downstream along the delay path in the order of the effect charges to be ignited.

Abstract: An apparatus for determining an interference in a transmission medium during a transmission of a data input signal according to an embodiment has a transform module configured to transform the data input signal from a time domain to a frequency domain comprising a plurality of frequency channels to obtain a frequency-domain data signal comprising a plurality of spectral coefficients, wherein each spectral coefficient is assigned to one of the frequency channels, an analysis module configured to determine the interference by determining one or more spectral interference coefficients, wherein each spectral interference coefficient is assigned to one frequency channel.

Abstract: A method for evaluation of a thin-layer chromatography plate after performing a separation process that separates components of a sample on the thin-layer chromatography plate comprises a digitization step, wherein at least two digital images are taken that differ with respect to the wavelength range of illumination of the thin-layer chromatography plate. The method further comprises a position identification step wherein the position of the thin-layer chromatography plate is identified for each of the at least two digital images. Furthermore, the method comprises an evaluation step wherein an image information of the at least two digital images is superimposed for at least all regions with at least one visible spot within at least one of the at least two digital images, so that the superimposition of image information from identical regions of at least two digital images can be used for evaluation of the thin-layer chromatography.

Abstract: A thin-layer chromatography development chamber (1) that can be used for developing thin-layer chromatography plates (21) by introducing a liquid solvent onto a sample arranged on the surface of a thin-layer chromatography plate (21), whereby the solvent and the thin-layer chromatography plate (21) can be inserted into the development chamber (1), comprises a housing (2) with an opening (3). The opening (3) of the development chamber (1) can be closed with a cover (4) that comprises a data input unit (10) for entering or collecting data related to a development process performed within the development chamber (1). The cover (4) further comprises a data communication unit (16) that enables a wireless data transmission of the data related to the development process to a thin-layer chromatography data storage device (24).

Abstract: A device and a method for calibrating a light projector (1) with adaptable luminous elements (3) arranged in an image plane (2), comprising a camera (4) and a control unit (5) connected to the light projector (1) and the camera (4), wherein the light projector (1) is configured to project in temporal succession at least two test images (6, 6?) with at least two comparison structures (9, 9?) from the image plane (2) to an arbitrarily extending projection surface (7), the camera (4) is a depth camera configured to record at least two camera images of a recording surface (8) in a manner substantially synchronized temporally with the light projector (1), and to detect the three-dimensional position data of the comparison structures (9, 9?) in the camera images, and the control unit (5) is configured to determine the position and orientation of the light projector (1), and to calculate the translational displacement and rotational twist between camera (4) and projector (1).

Abstract: The present invention provides compounds (n-3 PUFA derivatives) of formula (I): that modulate conditions associated with cardiac damage, especially cardiac arrhythmias.

Abstract: An apparatus for determining an interference in a transmission medium during a transmission of a data input signal according to an embodiment has a transform module configured to transform the data input signal from a time domain to a frequency domain comprising a plurality of frequency channels to obtain a frequency-domain data signal comprising a plurality of spectral coefficients, wherein each spectral coefficient is assigned to one of the frequency channels, an analysis module configured to determine the interference by determining one or more spectral interference coefficients, wherein each spectral interference coefficient is assigned to one frequency channel.

Abstract: A method for testing a device under test at a specific channel condition is provided. The method comprises the steps of initiating a communication with the device under test and receiving a transmission frame from the device under test with a header portion comprising a specific transmission rate information. It also comprises analyzing the header portion of the transmission frame in order to determine whether the device under test is transmitting with the specific transmission rate information.

Abstract: The present invention relates to compounds according to general formula (I) which are metabolically robust analogues of bioactive lipid mediators derived from omega-3 polyunsaturated fatty acids (n-3 PUFAs) for use in treating or reducing the risk of developing or preventing: (i) neovascularization and/or (ii) inflammatory disorder, in particular, ophthalmic disorders associated with neovascularization and/or inflammation.

Abstract: The present invention relates to compounds according to general formula (I) which are analogues of epoxymetabolites produced by cytochrome P450 (CYP) enzymes from omega-3 (n-3) polyunsaturated fatty acids (PUFAs). The present invention further relates to compositions containing one or more of these compounds and to the use of these compounds or compositions for the treatment or prevention of conditions and diseases associated with inflammation, proliferation, hypertension, coagulation, immune function, pathologic angiogenesis, heart failure and cardiac arrhythmias.

Abstract: The present invention relates to compounds according to general formula (I) which are metabolically robust analogues of bioactive lipid mediators derived from omega-3 polyunsaturated fatty acids (n-3 PUFAs). The present invention further relates to compositions containing one or more of these compounds and to the use of these compounds or compositions for the treatment or prevention of cardiovascular diseases.

Abstract: A method for testing a device under test at a specific channel condition is provided. The method comprises the steps of initiating a communication with the device under test and receiving a transmission frame from the device under test with a header portion comprising a specific transmission rate information. It also comprises analyzing the header portion of the transmission frame in order to determine whether the device under test is transmitting with the specific transmission rate information.

Abstract: A multi-antenna receiver comprises two or more antennas configured to receive RF signals, pre-filter circuitry configured to split, per antenna, the RF signal received by the respective antenna into two or more sub-signals in different signal bands, selection circuitry configured to select, per signal band, one or more sub-signals according to a selection criterion and to combine, per signal band, the selected sub-signals to obtain a combined signal per signal band, analog-to-digital conversion circuitry configured to convert, per signal band, the combined signals into the digital domain, and recombining circuitry configured to recombine the combined signals converted into the digital domain to obtain a reconstructed signal.

Abstract: The present invention provides compounds (n-3 PUFA derivatives) of formula (I): that modulate conditions associated with cardiac damage, especially cardiac arrhythmias.

Abstract: A system, method and computer readable medium for secure file transfer is disclosed. In one embodiment, the system encrypts a file; sends, via a secure channel, a packet to a group having one or more members, the group authorized to access the encrypted file, the packet associated with the encrypted file and including access information for the encrypted file; receives a first request for the encrypted file from a first requestor; and sends the encrypted file to the first requestor via an unsecured channel that performs caching, wherein the first requestor is able to access the encrypted file using the packet when the first requestor is a member of the group authorized to access the encrypted file and received the packet via the secure channel and unable to access the encrypted file when the first requestor is not a member of the group authorized to access the encrypted file.